Search
The Newsletter
The Principals
Reports
Conferences
Physician Surveys
Consulting
Contact Us
Home


Pricing and Ordering Information


                                         
Gynecologists' Adoption of New Technologies

  •  Which ablation technology do gynecologists think has the highest amenorrhea rate?

  • What is most important to gynecologists when choosing a global ablation system?

Medtech Insight asked these and other key questions at the Global Congress of 
Gynecologic Endoscopy
, the American Association of Gynecological Laparoscopists’ 
(AAGL) 30th Annual Meeting in November 2001.  Our Pr3 Physician Survey
from this 
event includes questions on key topics including:  myomectomy, laparoscopy, 
hysterectomy, endometrial ablation, stress incontinence, and operative 
hysteroscopy


Research Methods
Over 150 physicians participated in the survey, which was conducted using audience 
response technology over a three-day period. Sample size varied from question to 
question and averaged 63 respondents per question. Physicians attending the 
conference were asked a total of 100 questions (listed below).

SURVEY QUESTIONS
   (n=sample size)

Demographics

1.            Which of the following subgroups BEST describes you? (n=79)

2.            Are you a… (n=156)

3.            Where are you from? (n=156)

4.            If you are from the US, in what region of the country do you practice? (n=125)

5.            What is your practice ownership? (n=153)

 

Myomectomy

6.            How often do you perform hysteroscopic myomectomy? (n=96)

7.            How often do you perform laparoscopic myomectomy (lesion >3 cm in size)? (n=98)

8.            How many myomectomy procedures do you perform per month? (n=28)

9.            I perform the majority of my myomectomies by: (n=33)

10.        How many myolysis procedures did you perform during the last 12 months? (n=26)

11.        What is the principal reason that you do not perform laparoscopic myolysis? (n=21)

12.        I treat infertility patients in my practice. (n=33)

13.        I perform the majority of my intramural myomectomies by: (n=32)

14.        In the infertile patient with intramural fibroids and no other infertility etiology, I will perform a myomectomy: (n=33)

15.        In an infertile patient with a single 6 cm intramural fibroid and no other cause for infertility, I believe a myomectomy is: (n=32)

16.        In an infertile patient with a single 6 cm intramural fibroid and no other cause of infertility and a history of spontaneous abortion, I believe a myomectomy is: (n=33)

17.        In an infertile patient with a single 3 cm intramural fibroid and no other cause for infertility, I believe a myomectomy is: (n=34)

18.        An infertile patient with a single 3 cm intramural fibroid and no other cause for infertility fails to conceive with Clomid/IUI and Gonadotropin/IUI therapy. Before her first cycle of 
in vitro
fertilization, I believe a myomectomy is: (n=34)

19.        As a result of this debate, I will change my practice habits when treating an infertile woman with an intramural fibroid: (n=29)

 

Laparoscopy/Hysterectomy

20.        How many laparoscopic procedures do you perform per month? (n=150)

21.        Compared to last year, will the number of laparoscopic procedures that you perform this year… (n=149)

22.        How many hysterectomies do you perform per week? (n=68)

23.        How often do you perform LAVH? (n=97)

24.        How often do you perform total or supracervical laparoscopic hysterectomy? (n=97)

25.        I predict that in the near future, the numbers of laparoscopic surgeries performed
will … (n=32)

26.        When performing a laparoscopic procedure, do you PRIMARILY use reusable or disposable trocars? (n=73)

27.        At what size should hysterectomy be recommended, regardless of symptoms? (n=72)

28.        What type of laparoscopic hysterectomy do you most frequently perform? (n=44)

29.        When performing a laparoscopic hysterectomy, which instrument do you PRIMARILY use to transect the broad ligament? (n=76)

30.        When performing a laparoscopic hysterectomy, which instrument do you PRIMARILY use, to transect the IP ligament? (n=73)

31.        When performing a laparoscopic hysterectomy, which instrument do you PRIMARILY use, to transect the uterine artery? (n=78)

32.        Have you ever accidentally injured a major retroperitoneal vessel during insertion of a Veress needle or trocar? (n=42)

33.        What is the biggest obstacle to performing a laparoscopic hysterectomy? (n=89)

34.        Which of the following do you consider to be the BIGGEST contraindication to vaginal hysterectomy? (n=72)

35.        At what age should normal ovaries be routinely removed during hysterectomy?  (n=72)

36.        Does unilateral salpingoopherectomy increase the risk of premature menopause? (n=80)

37.        In the evaluation of a patient with endometriosis, which of the following would be MOST important and accurate to review? (n=82)

38.        If a videotape is the best record of the findings at laparoscopy, would you consider recording the procedure? (n=78)

39.        Of the following laparoscopic tasks, which do you find most challenging? (n=42)

40.        How do you feel about your laparoscopic stitching and knot-tying abilities? (n=93)

41.        Do you advise a formal bowel preparation for all of your laparoscopic surgery? (n=44)

42.        Have you ever accidentally injured the ureter during laparoscopic hysterectomy? (n=48)

43.        Have you ever had formal training in electrosurgery? (n=57)

44.        How do you typically manage laparoscopically- discovered pelvic endometriosis? (n=42)

45.        I have been independently performing advanced laparoscopic surgery for… (n=42)

46.        What is the best way to develop laparoscopic skills? (n=102)

47.        How much do you know about acquiring skills through simulation? (n=99)

48.        It is possible to measure laparoscopic skills with objective means. (n=98)

49.        Objective skill assessment for the purpose of personal development and
self-assessment is a good thing. (n=97)

 

Endometrial Ablation

50.        How many patients do you see per week with abnormal uterine bleeding that are indicated for treatment? (n=147)

51.        Do you perform endometrial ablation procedures? (n=156)

52.        How many endometrial ablation procedures do you perform per week?  (n=33)

53.        How often do you perform hysteroscopic endometrial resection or roller ball ablation? (n=92)

54.        Compared to last year, will the number of endometrial ablation procedures that you perform this year… (n=148)

55.        Which of the following endometrial ablation treatments do you use the MOST? (n=36)

56.        Which technology in your opinion has the highest rate of amenorrhea? (n=40)

57.        Which of the following endometrial ablation technologies do you think shows the greatest promise in controlling abnormal uterine bleeding?  (n=42)

58.        What is the BIGGEST obstacle affecting your choice of treatment for AUB? (n=31)

59.        How many patients do you see per week who are candidates for global ablation? (n=21)

60.        If you currently perform global ablation, where did you receive your training? (n=38)

61.        What is most important to you when choosing a global ablation system?  (n=41)

62.        What is the ONE most significant challenge to widespread adoption of global ablation technology amongst physicians? (n=29)

63.        The uterine cavity, following global ablation, is similar to that seen in classic cases of Asherman's Syndrome. (n=29)

64.        What is most important to you when choosing a global ablation system? (n=40)

65.        Assuming equal safety of all global ablation procedures, which of the following would be MOST important to you in choosing a particular technology? (n=31)

66.        Which one of the following global ablation technologies is not automated and
self-terminating? (n=22)

67.        Which global ablation system do you currently use? (n=28)

 

Stress Incontinence

68.        How many patients do you see per week with stress incontinence in need of treatment? (n=69)

69.        What is the first line of treatment in these patients? (n=71)

70.        How many stress urinary incontinence procedures do you perform per month? (n=72)

71.        If you currently treat stress incontinence surgery, how did you receive your training? (n=65)

72.        Which of the following treatments for management of stress urinary incontinence do you use the MOST? (n=73)

73.        Of the following treatments for management of stress urinary incontinence, which do you think will experience the MOST growth in the next 3-5 years? (n=62)

74.        Of the minimally invasive therapies used to treat stress urinary incontinence, which do you feel will experience the most growth in the next 3-5 years? (n=71)

75.        If you use minimally invasive therapies to treat stress urinary incontinency, which do you use the MOST? (n=72)

76.        What material do you use the most in a sling procedure? (n=59)

77.        What material do you think will experience the most growth in the next 3-5 years for sling procedures? (n=60)

 

Operative Hysteroscopy

78.        Do you perform operative hysteroscopy? (n=30)

79.        How many operative hysteroscopic procedures do you perform per week? (n=29)

80.        How many operative hysteroscopic procedures do you perform per month? (n=148)

81.        Which operative hysteroscopic system do you currently use? (n=30)

82.        Compared to last year, will the number of operative hysteroscopic procedures that you perform this year… (n=151)

83.        What is the principal reason that you do not perform operative hysteroscopy? (n=73)

84.        If financial reimbursement to perform operative hysteroscopy was increased so that it was comparable to other surgical options (e.g., hysterectomy) how would it affect the frequency of your performance of this procedure? (n=29)

85.        Which of the following do you consider to be the BIGGEST obstacle to your performing operative hysteroscopy? (n=28)

86.        If you currently perform operative hysteroscopy, how did you receive your training? (n=31)

87.        If you currently do not perform operative hysteroscopy, how would you like to be trained? (n=29)

88.        What would motivate you to take a course in operative hysteroscopy? (n=35)

89.        I perform fluid management by: (n=40)

90.        Which fluid management system do you currently use the MOST? (n=27)

91.        Why do you use this system? (n=37)

92.        When performing operative hysteroscopy, which of the following mediums do you use the MOST for fluid distension? (n=44)

93.        Which of the following fluid distension mediums used in operative hysteroscopy do you think will experience the MOST growth in the next 3-5 years? (n=48)

94.        Which of the following energy sources do you use the MOST for operative hysteroscopy? (n=37)

95.        I have had a case of hyponatremia with hysteroscopy. (n=38)

96.        I have had the following number of hyponatremia cases: (n=34)

97.        I have had a case of infection following operative hysteroscopy. (n=39)

98.        I routinely use prophylactic antibiotics for operative hysteroscopy. (n=45)

99.        I have had a case of suspected gas embolism with operative hysteroscopy. (n=50)

100.    I have had a case of severe hemorrhage following operative hysteroscopy. (n=48)

© 2001, Medtech Insight, LLC


Ordering Information

Physician Survey #

# of Questions Format Price

PS301, Gynecologists' Adoption of New Technologies
Pr3 Physician Survey questions and responses on demographics, myomectomy, laparoscopy/hysterectomy, endometrial ablation, stress incontinence, operative hysteroscopy. 

100

PowerPoint/
CD-ROM

$3,900


To purchase the results of this survey or for further inquiries, please contact 
pr3@medtechinsight.com
or call our sales office at (949) 219-0150 or toll 
free in the U.S. at (888) 290-2225.


The Newsletter
| The Principals | Reports | Conferences | Physician Surveys |
Consulting | Contact Us | Home